{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T23:47:14Z","timestamp":1792194434524,"version":"4.4.0"},"reference-count":52,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2023,8,21]],"date-time":"2023-08-21T00:00:00Z","timestamp":1692576000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Current Oncology"],"abstract":"<jats:p>Background: To evaluate the use of stereotactic body radiation therapy (SBRT) for spine metastases and the associated factors in Australia. Methods: The Victorian Radiotherapy Minimum Dataset, which captures all episodes of radiotherapy delivered in the state of Victoria, was accessed to evaluate the patterns and trends of SBRT for spine metastases. The primary outcome was SBRT use and associated factors. Results: There were 6244 patients who received 8861 courses of radiotherapy for spine metastases between 2012 and 2017. Of these, 277 (3%) courses were SBRT, which increased from 0.4% in 2012 to 5% in 2017 (P-trend &lt; 0.001). There was a higher proportion of SBRT use in patients with prostate cancer (6%) and melanoma (4%) compared to other cancers (2\u20133%) (p &lt; 0.001). Patients from the highest socioeconomic quintiles (5%) were more likely to be treated with SBRT compared to patients from the lowest socioeconomic quintiles (3%) (p &lt; 0.001). There was a higher proportion of SBRT use in private radiotherapy centres (6%) compared to public radiotherapy centres (1%) (p &lt; 0.001). No spine SBRT was delivered in regional centres. In multivariate analyses, the year of treatment, age, primary cancers and radiotherapy centres were independently associated with SBRT use. Conclusion: This is the first Australian population-based study quantifying the increasing use of spine SBRT; however, the overall use of spine SBRT remains low. We anticipate an ongoing increase in spine SBRT, as spine SBRT gradually becomes the standard-of-care treatment for painful spine metastases.<\/jats:p>","DOI":"10.3390\/curroncol30080564","type":"journal-article","created":{"date-parts":[[2023,8,22]],"date-time":"2023-08-22T00:57:52Z","timestamp":1692665872000},"page":"7777-7788","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Stereotactic Body Radiation Therapy for Spine Metastases\u2014Findings from an Australian Population-Based Study"],"prefix":"10.3390","volume":"30","author":[{"given":"Wee Loon","family":"Ong","sequence":"first","affiliation":[{"name":"Alfred Health Radiation Oncology, Melbourne 3004, Australia"},{"name":"Central Clinical School, Monash University, Melbourne 3004, Australia"},{"name":"School of Clinical Medicine, University of Cambridge, Cambridge CB2 0SP, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger L.","family":"Milne","sequence":"additional","affiliation":[{"name":"Cancer Epidemiology Division, Cancer Council Victoria, Melbourne 3004, Australia"},{"name":"Centre for Epidemiology and Biostatistics, School of Population and Global Health, University of Melbourne, Melbourne 3053, Australia"},{"name":"Precision Medicine, School of Clinical Sciences, Monash Health, Monash University, Melbourne 3168, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farshad","family":"Foroudi","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Olivia Newton-John Cancer Wellness and Research Centre, Austin Health, Heidelberg 3084, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8202-8602","authenticated-orcid":false,"given":"Jeremy L.","family":"Millar","sequence":"additional","affiliation":[{"name":"Alfred Health Radiation Oncology, Melbourne 3004, Australia"},{"name":"Central Clinical School, Monash University, Melbourne 3004, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,8,21]]},"reference":[{"key":"ref_1","first-page":"i5","article-title":"Epidemiology of spinal cord and column tumors","volume":"7","author":"Wewel","year":"2020","journal-title":"Neurooncol. Pract."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/S0140-6736(05)66954-1","article-title":"Direct decompressive surgical resection in the treatment of spinal cord compression caused by metastatic cancer: A randomised trial","volume":"366","author":"Patchell","year":"2005","journal-title":"Lancet"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1016\/j.spinee.2021.04.012","article-title":"Spinal metastases 2021: A review of the current state of the art and future directions","volume":"21","author":"Sciubba","year":"2021","journal-title":"Spine J."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"e720","DOI":"10.1016\/S1470-2045(17)30612-5","article-title":"An integrated multidisciplinary algorithm for the management of spinal metastases: An International Spine Oncology Consortium report","volume":"18","author":"Spratt","year":"2017","journal-title":"Lancet Oncol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"100320","DOI":"10.1016\/j.jbo.2020.100320","article-title":"Separation surgery for metastatic epidural spinal cord compression: A qualitative review","volume":"25","author":"Cofano","year":"2020","journal-title":"J. Bone Oncol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.radonc.2018.04.030","article-title":"Randomized phase II trial evaluating pain response in patients with spinal metastases following stereotactic body radiotherapy versus three-dimensional conformal radiotherapy","volume":"128","author":"Sprave","year":"2018","journal-title":"Radiother. Oncol. J. Eur. Soc. Ther. Radiol. Oncol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/S1470-2045(21)00196-0","article-title":"Stereotactic body radiotherapy versus conventional external beam radiotherapy in patients with painful spinal metastases: An open-label, multicentre, randomised, controlled, phase 2\/3 trial","volume":"22","author":"Sahgal","year":"2021","journal-title":"Lancet Oncol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1001\/jamaoncol.2023.0356","article-title":"Stereotactic Radiosurgery vs Conventional Radiotherapy for Localized Vertebral Metastases of the Spine: Phase 3 Results of NRG Oncology\/RTOG 0631 Randomized Clinical Trial","volume":"9","author":"Ryu","year":"2023","journal-title":"JAMA Oncol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.clon.2022.02.005","article-title":"The Changing Landscape for the Treatment of Painful Spinal Metastases: Is Stereotactic Body Radiation Therapy the New Standard of Care?","volume":"34","author":"Dunne","year":"2022","journal-title":"Clin. Oncol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1080\/14737140.2018.1493381","article-title":"The evolution and rise of stereotactic body radiotherapy (SBRT) for spinal metastases","volume":"18","author":"Vellayappan","year":"2018","journal-title":"Expert Rev. Anticancer Ther."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1001\/jamaoncol.2019.5351","article-title":"Stereotactic Ablative Radiotherapy for the Management of Spinal Metastases: A Review","volume":"6","author":"Glicksman","year":"2020","journal-title":"JAMA Oncol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.semradonc.2022.11.006","article-title":"Stereotactic Body Radiation Therapy for Spinal Metastases: Benefits and Limitations","volume":"33","author":"Guckenberger","year":"2023","journal-title":"Semin. Radiat. Oncol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1016\/S0140-6736(18)32487-5","article-title":"Stereotactic ablative radiotherapy versus standard of care palliative treatment in patients with oligometastatic cancers (SABR-COMET): A randomised, phase 2, open-label trial","volume":"393","author":"Palma","year":"2019","journal-title":"Lancet"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.radonc.2021.08.011","article-title":"An international pooled analysis of SBRT outcomes to oligometastatic spine and non-spine bone metastases","volume":"164","author":"Cao","year":"2021","journal-title":"Radiother. Oncol. J. Eur. Soc. Ther. Radiol. Oncol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s11060-020-03691-6","article-title":"Local control and patterns of failure for \u201cRadioresistant\u201d spinal metastases following stereotactic body radiotherapy compared to a \u201cRadiosensitive\u201d reference","volume":"152","author":"Zeng","year":"2021","journal-title":"J. Neurooncol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"E6","DOI":"10.3171\/2016.9.FOCUS16369","article-title":"The impact of histology and delivered dose on local control of spinal metastases treated with stereotactic radiosurgery","volume":"42","author":"Yamada","year":"2017","journal-title":"Neurosurg. Focus"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"100665","DOI":"10.1016\/j.adro.2021.100665","article-title":"Characteristics and Predictors of Radiographic Local Failure in Patients With Spinal Metastases Treated With Palliative Conventional Radiation Therapy","volume":"6","author":"Chen","year":"2021","journal-title":"Adv. Radiat. Oncol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.clon.2017.11.005","article-title":"Re-irradiation of Vertebral Body Metastases: Treatment in the Radiosurgery Era","volume":"30","author":"Myrehaug","year":"2018","journal-title":"Clin. Oncol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1016\/j.jocn.2015.01.030","article-title":"Technique and early clinical outcomes for spinal and paraspinal tumours treated with stereotactic body radiotherapy","volume":"22","author":"Finnigan","year":"2015","journal-title":"J. Clin. Neurosci."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"e119","DOI":"10.1016\/j.clon.2017.02.004","article-title":"Stereotactic Ablative Body Radiotherapy for the Treatment of Spinal Oligometastases","volume":"29","author":"Chang","year":"2017","journal-title":"Clin. Oncol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.clon.2020.02.030","article-title":"Vertebral Fractures Following Stereotactic Body Radiotherapy for Spine Oligometastases: A Multi-institutional Analysis of Patient Outcomes","volume":"32","author":"Abbouchie","year":"2020","journal-title":"Clin. Oncol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1111\/1754-9485.13407","article-title":"Disparities in radiation therapy utilization for cancer patients in Victoria","volume":"66","author":"Ong","year":"2022","journal-title":"J. Med. Imaging Radiat. Oncol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.jocn.2017.08.007","article-title":"Spinal stereotactic body radiotherapy in the United States: A decade-long nationwide analysis of patient demographics, practice patterns, and trends over time","volume":"46","author":"McClelland","year":"2017","journal-title":"J. Clin. Neurosci."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1177\/0825859720982204","article-title":"Disparities in Patterns of Conventional Versus Stereotactic Body Radiotherapy in the Treatment of Spine Metastasis in the United States","volume":"36","author":"Kim","year":"2021","journal-title":"J. Palliat. Care"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.eururo.2018.06.004","article-title":"Stereotactic Abative Body Radiotherapy (SABR) for Oligometastatic Prostate Cancer: A Prospective Clinical Trial","volume":"74","author":"Siva","year":"2018","journal-title":"Eur. Urol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.breast.2019.10.016","article-title":"Stereotactic ablative body radiotherapy (SABR) for bone only oligometastatic breast cancer: A prospective clinical trial","volume":"49","author":"David","year":"2020","journal-title":"Breast"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.ijrobp.2022.05.043","article-title":"Mature Local Control and Reirradiation Rates Comparing Spine Stereotactic Body Radiotherapy to Conventional Palliative External Beam Radiotherapy","volume":"114","author":"Zeng","year":"2022","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.radonc.2021.02.011","article-title":"Survival after palliative radiation therapy for cancer: The METSSS model","volume":"158","author":"Zaorsky","year":"2021","journal-title":"Radiother. Oncol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1002\/cncr.28408","article-title":"Predicting life expectancy in patients with metastatic cancer receiving palliative radiotherapy: The TEACHH model","volume":"120","author":"Krishnan","year":"2014","journal-title":"Cancer"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"e2119568","DOI":"10.1001\/jamanetworkopen.2021.19568","article-title":"Causes of Death Among Patients With Metastatic Prostate Cancer in the US From 2000 to 2016","volume":"4","author":"Elmehrath","year":"2021","journal-title":"JAMA Netw. Open"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1200\/OP.21.00206","article-title":"Recent Advances in the Management of Metastatic Prostate Cancer","volume":"18","author":"Sayegh","year":"2022","journal-title":"JCO Oncol. Pr."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"3947","DOI":"10.1200\/JCO.20.00198","article-title":"Systemic Therapy for Melanoma: ASCO Guideline","volume":"38","author":"Seth","year":"2020","journal-title":"J. Clin. Oncol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.jocn.2010.04.033","article-title":"Technique for stereotactic body radiotherapy for spinal metastases","volume":"18","author":"Foote","year":"2011","journal-title":"J. Clin. Neurosci."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1111\/1754-9485.13381","article-title":"Patterns of the use of advanced radiation therapy techniques for the management of bone metastases and the associated factors in Victoria","volume":"66","author":"Fogarty","year":"2022","journal-title":"J. Med. Imaging Radiat. Oncol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s11060-022-04037-0","article-title":"Radiation myelopathy following stereotactic body radiation therapy for spine metastases","volume":"159","author":"Ong","year":"2022","journal-title":"J. Neurooncol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"e595","DOI":"10.1016\/S1470-2045(15)00166-7","article-title":"Response assessment after stereotactic body radiotherapy for spinal metastasis: A report from the SPIne response assessment in Neuro-Oncology (SPINO) group","volume":"16","author":"Thibault","year":"2015","journal-title":"Lancet Oncol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"218","DOI":"10.21037\/atm.2019.01.65","article-title":"Intra- and interobserver reliability of the Spinal Instability Neoplastic Score system for instability in spine metastases: A systematic review and meta-analysis","volume":"7","author":"Pennington","year":"2019","journal-title":"Ann. Transl. Med."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"324","DOI":"10.3171\/2010.3.SPINE09459","article-title":"Reliability analysis of the epidural spinal cord compression scale","volume":"13","author":"Bilsky","year":"2010","journal-title":"J. Neurosurg. Spine"},{"key":"ref_39","first-page":"278","article-title":"Safety and clinical efficacy of immune checkpoint inhibition and stereotactic body radiotherapy in patients with spine metastasis","volume":"39","author":"Lee","year":"2023","journal-title":"J. Neurosurg. Spine"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1001\/jamaoncol.2021.7008","article-title":"Development and Assessment of a Predictive Score for Vertebral Compression Fracture After Stereotactic Body Radiation Therapy for Spinal Metastases","volume":"8","author":"Kowalchuk","year":"2022","journal-title":"JAMA Oncol."},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Ito, K., Taguchi, K., Nakajima, Y., Ogawa, H., Sugita, S., and Murofushi, K.N. (2023). Incidence and Prognostic Factors of Painful Vertebral Compression Fracture Caused by Spine Stereotactic Body Radiotherapy. J. Clin. Med., 12.","DOI":"10.3390\/jcm12113853"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"101220","DOI":"10.1016\/j.adro.2023.101220","article-title":"Planning for the Effect of the SC.24 Trial on Spine Stereotactic Body Radiation Therapy Utilization at a Tertiary Cancer Center","volume":"8","author":"Arifin","year":"2023","journal-title":"Adv. Radiat. Oncol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"pkx003","DOI":"10.1093\/jncics\/pkx003","article-title":"Adoption of Stereotactic Body Radiotherapy for Stage IA Non-Small Cell Lung Cancer Across the United States","volume":"1","author":"Holmes","year":"2017","journal-title":"JNCI Cancer Spectr."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"e109","DOI":"10.1016\/j.ijrobp.2012.08.007","article-title":"Use of stereotactic radiosurgery for brain metastases from non-small cell lung cancer in the United States","volume":"85","author":"Halasz","year":"2013","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1080\/0284186X.2018.1562207","article-title":"Stereotactic radiosurgery for brain metastases from newly diagnosed small cell lung cancer: Practice patterns and outcomes","volume":"58","author":"Jiang","year":"2019","journal-title":"Acta Oncol."},{"key":"ref_46","first-page":"e4031","article-title":"Disparities in the Use of Single-fraction Stereotactic Radiosurgery for the Treatment of Brain Metastases From Non-small Cell Lung Cancer","volume":"11","author":"Modh","year":"2019","journal-title":"Cureus"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"526","DOI":"10.5694\/mja2.50573","article-title":"Stereotactic radiosurgery for managing brain metastases in Victoria, 2012\u20132017","volume":"212","author":"Ong","year":"2020","journal-title":"Med. J. Aust."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.clon.2022.02.010","article-title":"UK 2022 Consensus on Normal Tissue Dose-Volume Constraints for Oligometastatic, Primary Lung and Hepatocellular Carcinoma Stereotactic Ablative Radiotherapy","volume":"34","author":"Diez","year":"2022","journal-title":"Clin. Oncol."},{"key":"ref_49","first-page":"33","article-title":"Recommendations for stereotactic body radiation therapy for spine and non-spine bone metastases. A GETUG (French society of urological radiation oncolgists) consensus using a national two-round modified Delphi survey","volume":"37","author":"Vilotte","year":"2022","journal-title":"Clin. Transl. Radiat. Oncol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.clon.2012.04.006","article-title":"The Canadian Association of Radiation Oncology scope of practice guidelines for lung, liver and spine stereotactic body radiotherapy","volume":"24","author":"Sahgal","year":"2012","journal-title":"Clin. Oncol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"207","DOI":"10.3171\/2012.11.SPINE12111","article-title":"Local disease control for spinal metastases following \u201cseparation surgery\u201d and adjuvant hypofractionated or high-dose single-fraction stereotactic radiosurgery: Outcome analysis in 186 patients","volume":"18","author":"Laufer","year":"2013","journal-title":"J. Neurosurg. Spine"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"E1111","DOI":"10.1093\/neuros\/nyz349","article-title":"Postoperative Stereotactic Body Radiotherapy for Spinal Metastases and the Impact of Epidural Disease Grade","volume":"85","author":"Alghamdi","year":"2019","journal-title":"Neurosurgery"}],"container-title":["Current Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1718-7729\/30\/8\/564\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T20:38:56Z","timestamp":1760128736000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1718-7729\/30\/8\/564"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,21]]},"references-count":52,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2023,8]]}},"alternative-id":["curroncol30080564"],"URL":"https:\/\/doi.org\/10.3390\/curroncol30080564","relation":{},"ISSN":["1718-7729"],"issn-type":[{"value":"1718-7729","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,21]]}}}